Paul A. Ragusa


New York

P: +1.212.408.2588
F: +

Paul Ragusa is a partner in the Intellectual Property section of the firm’s New York office. His practice encompasses high technology and Hatch-Waxman patent litigation, inter-partes reviews, IP portfolio management and licensing, including of standard-essential patents (SEPs).

His diverse technical experience spans audiovisual compression and transmission, semiconductor device fabrication, nanotechnology, artificial intelligence, software applications, techniques for delivering pharmaceutical products and medical devices. He was part of the team that drafted the patent licensing agreements directed to the MPEG-2 digital video compression standard, and continues to focus on Standard Development Organizations (SDOs), related Open Source Software (“OSS”) consortia, and licensing of SEPs, including 5G, 802.11, ARIB, ATSC, AV1, AVC, Blu-ray, CRISPR, DASH, DisplayPort, IETF, HEVC, LTE, MVC, UHDTV, VVC and WiFi-6.

Mr. Ragusa was named a New York Metro Super Lawyer and listed in IP Stars by Managing Intellectual Property for 2013-2022.  He was recommended in The Legal 500 U.S. guide for 2011-2015 & 2017-2021, in the latest edition for both licensing and prosecution (including post-grant proceedings), which wrote that he is “easy to work with” and has a “no nonsense approach.”  He was also recommended in the 2013-22 editions of the Intellectual Asset Management (IAM) Patent 1000, most recently for each of patent litigation, prosecution and transactions, and in IAM’s 2021-22 Strategy 300.  According to IAM, Paul is a “protean professional” and his “versatility manifests itself in his university work…acting for pharmaceutical companies and building on his expert knowledge of SEPs and antitrust law.” 

He is the programs subcommittee Chair of the American Intellectual Property Law Association’s Standards and Open Source Committee, Vice Chair of the Intellectual Property Owners’ (IPO) Standards Setting Committee, and serves on the Advisory Board at IP Litigator, using those positions to address the practical implications of important changes to the law.

Related Experience

  • Columbia University - development, management, licensing and litigation of a worldwide patent portfolio directed to a wide range of technologies, including audiovisual compression, medical devices, nanotechnology, artificial intelligence, bioinformatics, virtual reality, batteries, semiconductor device fabrication, and materials science, counseling concerning "SEPs", patent pools, and related licensing and litigation
  • Enghouse Systems & Vidyo, Inc. - patent litigation, conducting due diligence investigations, and counseling regarding Standard Development Organizations (SDOs), patent pools and OSS issues
  • Pharmacosmos A/S - IPRs, litigation and related counseling for patents related to parenteral iron therapy
  • Guangdong Mic-Power New Energy Co., Ltd., PEAG, LLC, D/B/A JLab Audio, Audio Partnership PLC d/b/a Cambridge Audio, and GN Audio A/S d/b/a Jabra - patent litigation, IPRs and related counseling for patents related to button cell batteries
  • Investor, USA - Hatch-Waxman Litigation and related counseling for patents directed to techniques for treating cancer
  • Ethypharm, S.A. - Hatch-Waxman litigation, licensing and counseling for patents related to methods of delivering pharmaceutical products
  • Pharmaceutical Company, Europe - IPRs and related counseling for patents directed to methods of treating nutrient deficiency conditions
  • The AES Corporation - Licensing and counseling regarding patents and know-how related to energy storage management
  • ECI Technologies, Inc. - development and management of a worldwide patent portfolio directed to semiconductor processing equipment and techniques, and related opinions, dispute resolution and licensing
  • Plasma Physics, Inc. - patent licensing and litigation, including trial of a patent infringement action resulting in a significant damages award for patents directed to plasma enhanced chemical vapor deposition
  • The University of Pennsylvania - development, management and licensing of a worldwide patent portfolio directed to life sciences technologies, including medical devices, diagnostic methods, pharmaceutical compositions and bioinformatics, and related counseling and opinions
  • The University of Pittsburgh - development of a worldwide patent portfolio directed to life sciences technologies, counseling regarding inventorship and patent ownership disputes and Bayh-Dole compliance
  • Allied Bolt, Inc. - complete range of intellectual property representation, including dispute resolution, conducting due diligence investigations, and development of a patent portfolio directed to fasteners

Awards & Community

Recognized as a New York Metro Super Lawyer (Thomson Reuters), 2013-2022

Recognized in IP Stars by Managing Intellectual Property, 2013-2022

Recommended by The Legal 500 U.S., 2011-2015 & 2017-2021

Recommended in the Intellectual Asset Management ("IAM") Magazine in Patent 1000 for patent litigation transactions, and prosecution, 2013-2022, and in the IAM Strategy 300, 2020-2022


results Page of

Thought Leadership

results Page of

The Future of AI Protection

External Article

The Journal of Robotics, Artificial Intelligence & Law, Volume 4, No. 1



results Page of

AIPLA 2019 Mid Winter Institute

Baker Botts is proud to participate in AIPLA's Mid-Winter Institute as sponsors of the opening night reception on January 30th and the Diversity Fun Run.